The downside of declassifying cannabis as a schedule 1 drug

Moving cannabis drugs away from Schedule 1 to Schedule 2 or lower would positively impact the national cannabis industry. But there is a downside, too.Cannabis

Related Keywords

Colorado , United States , Germany , Canada , Spain , Washington , Albert Gutierrez , Steve Hawkins , Steven Groff , Us Cannabis Council , Drug Enforcement Administration , Controlled Substances Act , Groff North America , Vice President , Columbia Care , Adam Goers , Politics ,